Key facts
- UpLyft (Therapeutic Devices)’s last known valuation is $6.6M (Jan 2021).
- It has raised $4.1M; the latest was Equity Crowdfunding ($830K) in Jan 2026.
- Notable investors include Innovate UK, 2468 Ventures, Rajit Malhotra, August Holding, Danube Angels — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for UpLyft (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for UpLyft (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About UpLyft (Therapeutic Devices)
Developer of a self-transfer system designed to help people with limited mobility. The company's system helps a person to self-transfer him/herself from a flat position in bed into their wheelchair, enabling patients to replace slings, body boards and other mechanisms that require nursing assistance and physical force to transfer individuals with mobility challenges.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2016
- Employees
- 8
- Website
- myuplyft.com/
- Ownership
- Privately Held (backing)
UpLyft (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in UpLyft (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on UpLyft (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.